<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36934642</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-035X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of infection and public health</Title><ISOAbbreviation>J Infect Public Health</ISOAbbreviation></Journal><ArticleTitle>Analysis of the nasopharyngeal microbiome and respiratory pathogens in COVID-19 patients from Saudi Arabia.</ArticleTitle><Pagination><StartPage>680</StartPage><EndPage>688</EndPage><MedlinePgn>680-688</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jiph.2023.03.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1876-0341(23)00067-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Infection with SARS-CoV-2 may perturb normal microbiota, leading to secondary infections that can complicate the viral disease. The aim of this study was to probe the alteration of nasopharyngeal (NP) microbiota in the context of SARS-CoV-2 infection and obesity and to identify other respiratory pathogens among COVID-19 cases that may affect patients' health.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 107 NP swabs, including 22 from control subjects and 85 from COVID-19 patients, were processed for 6S amplicon sequencing. The respiratory pathogens causing secondary infections were identified by RT-PCR assay, using a kit that contained specific primers and probes combinations to amplify 33 known respiratory pathogens.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">No significant (p &gt; 0.05) difference was observed in the alpha and beta diversity analysis, but specific taxa differed significantly between the control and COVID-19 patient groups. Genera of Sphingomonas, Kurthia, Microbacterium, Methylobacterium, Brevibacillus, Bacillus, Acinetobacter, Lactococcus, and Haemophilus was significantly abundant (p &lt; 0.05) in COVID-19 patients compared with a healthy control group. Staphylococcus was found in relatively high abundance (35.7 %) in the COVID-19 patient groups, mainly those treated with antibiotics. A relatively high percentage of Streptococcus was detected in COVID-19 patient groups with obesity or other comorbidities. Respiratory pathogens, including Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Salmonella species, along with Pneumocystis jirovecii fungal species were detected by RT-PCR mainly in the COVID-19 patients. Klebsiella pneumoniae was commonly found in most of the samples from the control and COVID-19 patients. Four COVID-19 patients had viral coinfections with human adenovirus, human rhinovirus, enterovirus, and human parainfluenza virus 1.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Overall, no substantial difference was observed in the predominant NP bacterial community, but specific taxa were significantly changed between the healthy control and COVID-19 patients. Comparatively, an increased number of respiratory pathogens were identified in COVID-19 patients, and NP colonization by K. pneumoniae was probably occurring in the local population.</AbstractText><CopyrightInformation>Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yasir</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia. Electronic address: yasirkhattak.mrl@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Sharif</LastName><ForeName>Hessa A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Subhi</LastName><ForeName>Tagreed</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sindi</LastName><ForeName>Anees A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Pulmonary &amp; Critical Care Consultant, International Medical Center, Jeddah 21589, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bokhary</LastName><ForeName>Diyaa H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Emergency Medicine Department, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah 21589, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Daly</LastName><ForeName>Mai M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alosaimi</LastName><ForeName>Bandar</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Research Center, King Fahad Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamed</LastName><ForeName>Maaweya E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Research Center, King Fahad Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Asad Mustafa</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Graduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin 17104, the Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Ahmed M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlShawdari</LastName><ForeName>Mustafa M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alawi</LastName><ForeName>Maha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Infection Control &amp; Environmental Health Unit, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah 21589, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Kafrawy</LastName><ForeName>Sherif A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azhar</LastName><ForeName>Esam I</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect Public Health</MedlineTA><NlmUniqueID>101487384</NlmUniqueID><ISSNLinking>1876-0341</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012529" MajorTopicYN="N" Type="Geographic">Saudi Arabia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009305" MajorTopicYN="N">Nasopharynx</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007711" MajorTopicYN="N">Klebsiella pneumoniae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">16S amplicon</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Nasopharyngeal microbiome</Keyword><Keyword MajorTopicYN="N">Saudi Arabia</Keyword><Keyword MajorTopicYN="N">Secondary infection</Keyword></KeywordList><CoiStatement>Competing interests None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>19</Day><Hour>19</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36934642</ArticleId><ArticleId IdType="pmc">PMC9984237</ArticleId><ArticleId IdType="doi">10.1016/j.jiph.2023.03.001</ArticleId><ArticleId IdType="pii">S1876-0341(23)00067-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Esper F.P., Adhikari T.M., Tu Z.J., Cheng Y.W., El-Haddad K., Farkas D.H., Bosler D., Rhoads D., Procop G.W., Ko J.S., et al. Alpha to omicron: disease severity and clinical outcomes of major SARS-CoV-2 variants. J Infect Dis. 2022 doi: 10.1093/infdis/jiac411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac411</ArticleId><ArticleId IdType="pmc">PMC9619650</ArticleId><ArticleId IdType="pubmed">36214810</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M., Rajnik M., Aleem A., Dulebohn S.C., Di Napoli R.: Features, Evaluation, and Treatment of Coronavirus (COVID-19). In StatPearls. Treasure Island (FL); 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Cekmen N., Ersoy Z., Gunay Y.I., Ghavam A.A., Tufan M.Y.S., Sahin I.M. Evaluation of coronavirus diseases (COVID-19) in terms of epidemiological and clinical features, comorbidities, diagnostic methods, treatment, and mortality. J Educ Health Promot. 2022;11:236. doi: 10.4103/jehp.jehp_1328_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jehp.jehp_1328_21</ArticleId><ArticleId IdType="pmc">PMC9514254</ArticleId><ArticleId IdType="pubmed">36177413</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford B.J., So M., Raybardhan S., Leung V., Westwood D., MacFadden D.R., Soucy J.R., Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622–1629. doi: 10.1016/j.cmi.2020.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.016</ArticleId><ArticleId IdType="pmc">PMC7832079</ArticleId><ArticleId IdType="pubmed">32711058</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafran N., Shafran I., Ben-Zvi H., Sofer S., Sheena L., Krause I., Shlomai A., Goldberg E., Sklan E.H. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci Rep. 2021;11(1):12703. doi: 10.1038/s41598-021-92220-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92220-0</ArticleId><ArticleId IdType="pmc">PMC8209102</ArticleId><ArticleId IdType="pubmed">34135459</ArticleId></ArticleIdList></Reference><Reference><Citation>Man W.H., de Steenhuijsen Piters W.A., Bogaert D. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol. 2017;15(5):259–270. doi: 10.1038/nrmicro.2017.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2017.14</ArticleId><ArticleId IdType="pmc">PMC7097736</ArticleId><ArticleId IdType="pubmed">28316330</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumpitsch C., Koskinen K., Schopf V., Moissl-Eichinger C. The microbiome of the upper respiratory tract in health and disease. BMC Biol. 2019;17(1):87. doi: 10.1186/s12915-019-0703-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-019-0703-z</ArticleId><ArticleId IdType="pmc">PMC6836414</ArticleId><ArticleId IdType="pubmed">31699101</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Karyakarte R., Joshi S., Das R., Jani K., Shouche Y., Sharma A. Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types. Microbes Infect. 2022;24(1) doi: 10.1016/j.micinf.2021.104880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2021.104880</ArticleId><ArticleId IdType="pmc">PMC8379005</ArticleId><ArticleId IdType="pubmed">34425246</ArticleId></ArticleIdList></Reference><Reference><Citation>Edouard S., Million M., Bachar D., Dubourg G., Michelle C., Ninove L., Charrel R., Raoult D. The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens. Eur J Clin Microbiol Infect Dis. 2018;37(9):1725–1733. doi: 10.1007/s10096-018-3305-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-018-3305-8</ArticleId><ArticleId IdType="pubmed">30033505</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugger S.D., Bomar L., Lemon K.P. Commensal-pathogen interactions along the human nasal passages. PLoS Pathog. 2016;12(7) doi: 10.1371/journal.ppat.1005633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005633</ArticleId><ArticleId IdType="pmc">PMC4936728</ArticleId><ArticleId IdType="pubmed">27389401</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury L., Lim B., Baskaran V., Lim W.S. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–275. doi: 10.1016/j.jinf.2020.05.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.05.046</ArticleId><ArticleId IdType="pmc">PMC7255350</ArticleId><ArticleId IdType="pubmed">32473235</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z., Peng F., Xu B., Zhao J., Liu H., Peng J., Li Q., Jiang C., Zhou Y., Liu S., et al. Risk factors of critical &amp; mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–e25. doi: 10.1016/j.jinf.2020.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7177098</ArticleId><ArticleId IdType="pubmed">32335169</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok S., Adam S., Ho J.H., Iqbal Z., Turkington P., Razvi S., Le Roux C.W., Soran H., Syed A.A. Obesity: a critical risk factor in the COVID-19 pandemic. Clin Obes. 2020;10(6) doi: 10.1111/cob.12403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cob.12403</ArticleId><ArticleId IdType="pmc">PMC7460880</ArticleId><ArticleId IdType="pubmed">32857454</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty A.B., Harrison E.M., Green C.A., Hardwick H.E., Pius R., Norman L., Holden K.A., Read J.M., Dondelinger F., Carson G., et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi: 10.1136/bmj.m1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Crovesy L., Masterson D., Rosado E.L. Profile of the gut microbiota of adults with obesity: a systematic review. Eur J Clin Nutr. 2020;74(9):1251–1262. doi: 10.1038/s41430-020-0607-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41430-020-0607-6</ArticleId><ArticleId IdType="pubmed">32231226</ArticleId></ArticleIdList></Reference><Reference><Citation>De Maio F., Posteraro B., Ponziani F.R., Cattani P., Gasbarrini A., Sanguinetti M. Nasopharyngeal microbiota profiling of SARS-CoV-2 infected patients. Biol Proced Online. 2020;22:18. doi: 10.1186/s12575-020-00131-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12575-020-00131-7</ArticleId><ArticleId IdType="pmc">PMC7382556</ArticleId><ArticleId IdType="pubmed">32728349</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventero M.P., Cuadrat R.R.C., Vidal I., Andrade B.G.N., Molina-Pardines C., Haro-Moreno J.M., Coutinho F.H., Merino E., Regitano L.C.A., Silveira C.B., et al. Nasopharyngeal microbial communities of patients infected with SARS-CoV-2 that developed COVID-19. Front Microbiol. 2021;12 doi: 10.3389/fmicb.2021.637430.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.637430</ArticleId><ArticleId IdType="pmc">PMC8010661</ArticleId><ArticleId IdType="pubmed">33815323</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueca M., Fontana A., Bartolini B., Piselli P., Mazzarelli A., Copetti M., Binda E., Perri F., Gruber C.E.M., Nicastri E., et al. Investigation of nasal/oropharyngeal microbial community of COVID-19 patients by 16S rDNA sequencing. Int J Environ Res Public Health. 2021;18(4) doi: 10.3390/ijerph18042174.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18042174</ArticleId><ArticleId IdType="pmc">PMC7926517</ArticleId><ArticleId IdType="pubmed">33672177</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun T., Halevi S., Hadar R., Efroni G., Glick Saar E., Keller N., Amir A., Amit S., Haberman Y. SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition. Sci Rep. 2021;11(1):8922. doi: 10.1038/s41598-021-88536-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88536-6</ArticleId><ArticleId IdType="pmc">PMC8076218</ArticleId><ArticleId IdType="pubmed">33903709</ArticleId></ArticleIdList></Reference><Reference><Citation>Budden K.F., Shukla S.D., Rehman S.F., Bowerman K.L., Keely S., Hugenholtz P., Armstrong-James D.P.H., Adcock I.M., Chotirmall S.H., Chung K.F., et al. Functional effects of the microbiota in chronic respiratory disease. Lancet Respir Med. 2019;7(10):907–920. doi: 10.1016/S2213-2600(18)30510-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(18)30510-1</ArticleId><ArticleId IdType="pubmed">30975495</ArticleId></ArticleIdList></Reference><Reference><Citation>Merenstein C., Bushman F.D., Collman R.G. Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance. Microbiome. 2022;10(1):165. doi: 10.1186/s40168-022-01342-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-022-01342-8</ArticleId><ArticleId IdType="pmc">PMC9532226</ArticleId><ArticleId IdType="pubmed">36195943</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks A.W., Priya S., Blekhman R., Bordenstein S.R. Gut microbiota diversity across ethnicities in the United States. PLoS Biol. 2018;16(12) doi: 10.1371/journal.pbio.2006842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2006842</ArticleId><ArticleId IdType="pmc">PMC6279019</ArticleId><ArticleId IdType="pubmed">30513082</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasir M., Angelakis E., Bibi F., Azhar E.I., Bachar D., Lagier J.C., Gaborit B., Hassan A.M., Jiman-Fatani A.A., Alshali K.Z., et al. Comparison of the gut microbiota of people in France and Saudi Arabia. Nutr Diabetes. 2015;5 doi: 10.1038/nutd.2015.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nutd.2015.3</ArticleId><ArticleId IdType="pmc">PMC4423199</ArticleId><ArticleId IdType="pubmed">25915742</ArticleId></ArticleIdList></Reference><Reference><Citation>Masella A.P., Bartram A.K., Truszkowski J.M., Brown D.G., Neufeld J.D. PANDAseq: paired-end assembler for illumina sequences. BMC Bioinforma. 2012;13:31. doi: 10.1186/1471-2105-13-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-13-31</ArticleId><ArticleId IdType="pmc">PMC3471323</ArticleId><ArticleId IdType="pubmed">22333067</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon S.H., Ha S.M., Kwon S., Lim J., Kim Y., Seo H., Chun J. Introducing EzBioCloud: a taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies. Int J Syst Evol Microbiol. 2017;67(5):1613–1617. doi: 10.1099/ijsem.0.001755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/ijsem.0.001755</ArticleId><ArticleId IdType="pmc">PMC5563544</ArticleId><ArticleId IdType="pubmed">28005526</ArticleId></ArticleIdList></Reference><Reference><Citation>Shetty S.A., van Beek J., Bijvank E., Groot J., Kuiling S., Bosch T., van Baarle D., Fuentes S. Associations and recovery dynamics of the nasopharyngeal microbiota during influenza-like illness in the aging population. Sci Rep. 2022;12(1):1915. doi: 10.1038/s41598-022-05618-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-05618-9</ArticleId><ArticleId IdType="pmc">PMC8813934</ArticleId><ArticleId IdType="pubmed">35115596</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong J., Liu P., Zhou G., Xia J. Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data. Nat Protoc. 2020;15(3):799–821. doi: 10.1038/s41596-019-0264-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-019-0264-1</ArticleId><ArticleId IdType="pubmed">31942082</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Teran A., Mejia-Nepomuceno F., Herrera M.T., Barreto O., Garcia E., Castillejos M., Boukadida C., Matias-Florentino M., Rincon-Rubio A., Avila-Rios S., et al. Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes. Sci Rep. 2021;11(1):21297. doi: 10.1038/s41598-021-00851-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00851-0</ArticleId><ArticleId IdType="pmc">PMC8556282</ArticleId><ArticleId IdType="pubmed">34716394</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu B., Yan Y., Dong L., Han L., Liu Y., Yu J., Chen J., Yi D., Zhang M., Deng X., et al. Integrated characterization of SARS-CoV-2 genome, microbiome, antibiotic resistance and host response from single throat swabs. Cell Disco. 2021;7(1):19. doi: 10.1038/s41421-021-00248-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00248-3</ArticleId><ArticleId IdType="pmc">PMC8008776</ArticleId><ArticleId IdType="pubmed">33785729</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa H.H., Fissel J.A., Fanelli B., Bergman Y., Gniazdowski V., Dadlani M., Carroll K.C., Colwell R.R., Simner P.J. Metagenomic next-generation sequencing of nasopharyngeal specimens collected from confirmed and suspect COVID-19 patients. mBio. 2020;11(6) doi: 10.1128/mBio.01969-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01969-20</ArticleId><ArticleId IdType="pmc">PMC7686804</ArticleId><ArticleId IdType="pubmed">33219095</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosas-Salazar C., Kimura K.S., Shilts M.H., Strickland B.A., Freeman M.H., Wessinger B.C., Gupta V., Brown H.M., Rajagopala S.V., Turner J.H., et al. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome. J Allergy Clin Immunol. 2021;147(4):1226–1233. doi: 10.1016/j.jaci.2021.02.001. e1222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2021.02.001</ArticleId><ArticleId IdType="pmc">PMC7871823</ArticleId><ArticleId IdType="pubmed">33577896</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y., Jia Z., Shi J., Wang W., He K. The active lung microbiota landscape of COVID-19 patients through the metatranscriptome data analysis. Bioimpacts. 2022;12(2):139–146. doi: 10.34172/bi.2021.23378.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/bi.2021.23378</ArticleId><ArticleId IdType="pmc">PMC8905590</ArticleId><ArticleId IdType="pubmed">35411293</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardelli C., Gentile I., Setaro M., Di Domenico C., Pinchera B., Buonomo A.R., Zappulo E., Scotto R., Scaglione G.L., Castaldo G., et al. Nasopharyngeal microbiome signature in COVID-19 positive patients: can we definitively get a role to fusobacterium periodonticum? Front Cell Infect Microbiol. 2021;11 doi: 10.3389/fcimb.2021.625581.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.625581</ArticleId><ArticleId IdType="pmc">PMC7919745</ArticleId><ArticleId IdType="pubmed">33659220</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar D., Pandit R., Sharma S., Raval J., Patel Z., Joshi M., Joshi C.G. Nasopharyngeal microbiome of COVID-19 patients revealed a distinct bacterial profile in deceased and recovered individuals. Micro Pathog. 2022;173(Pt A) doi: 10.1016/j.micpath.2022.105829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2022.105829</ArticleId><ArticleId IdType="pmc">PMC9568276</ArticleId><ArticleId IdType="pubmed">36252893</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardelli C., Scaglione G.L., Testa D., Setaro M., Russo F., Di Domenico C., et al. Nasal microbiome in COVID-19: a potential role of corynebacterium in anosmia. Curr Microbiol. 2022;80(1):53. doi: 10.1007/s00284-022-03106-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-022-03106-x</ArticleId><ArticleId IdType="pmc">PMC9802018</ArticleId><ArticleId IdType="pubmed">36583787</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M., Wang H., Luo H., Sun Y., Wang L., Ding S., et al. Characterization of the human oropharyngeal microbiomes in SARS-CoV-2 infection and recovery patients. Adv Sci (Weinh) 2021;8(20) doi: 10.1002/advs.202102785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.202102785</ArticleId><ArticleId IdType="pmc">PMC8529429</ArticleId><ArticleId IdType="pubmed">34423593</ArticleId></ArticleIdList></Reference><Reference><Citation>Bomar L., Brugger S.D., Yost B.H., Davies S.S., Lemon K.P. Corynebacterium accolens releases antipneumococcal free fatty acids from human nostril and skin surface triacylglycerols. mBio. 2016;7(1):e01725–01715. doi: 10.1128/mBio.01725-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01725-15</ArticleId><ArticleId IdType="pmc">PMC4725001</ArticleId><ArticleId IdType="pubmed">26733066</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo O., Locatello L.G., Mazzoni A., Novelli L., Annunziato F. The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection. Mucosal Immunol. 2021;14(2):305–316. doi: 10.1038/s41385-020-00359-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-020-00359-2</ArticleId><ArticleId IdType="pmc">PMC7690066</ArticleId><ArticleId IdType="pubmed">33244161</ArticleId></ArticleIdList></Reference><Reference><Citation>Knapp S., Brodal C., Peterson J., Qi F., Kreth J., Merritt J. Natural competence is common among clinical isolates of veillonella parvula and is useful for genetic manipulation of this key member of the oral microbiome. Front Cell Infect Microbiol. 2017;7:139. doi: 10.3389/fcimb.2017.00139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2017.00139</ArticleId><ArticleId IdType="pmc">PMC5397411</ArticleId><ArticleId IdType="pubmed">28473967</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Liu S., Zhang Z., Lee X., Wu W., Huang Z., et al. Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19. Synth Syst Biotechnol. 2021;6(3):135–143. doi: 10.1016/j.synbio.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.synbio.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8200311</ArticleId><ArticleId IdType="pubmed">34151035</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaibani P., Viciani E., Bartoletti M., Lewis R.E., Tonetti T., Lombardo D., et al. The lower respiratory tract microbiome of critically ill patients with COVID-19. Sci Rep. 2021;11(1):10103. doi: 10.1038/s41598-021-89516-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-89516-6</ArticleId><ArticleId IdType="pmc">PMC8115177</ArticleId><ArticleId IdType="pubmed">33980943</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao L., Zhang C., Dong J., Zhao L., Li Y., Sun J. Oral microbiome and SARS-CoV-2: beware of lung co-infection. Front Microbiol. 2020;11:1840. doi: 10.3389/fmicb.2020.01840.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01840</ArticleId><ArticleId IdType="pmc">PMC7411080</ArticleId><ArticleId IdType="pubmed">32849438</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalovich D., Rodriguez-Perez N., Smolinska S., Pirozynski M., Mayhew D., Uddin S., et al. Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients. Nat Commun. 2019;10(1):5711. doi: 10.1038/s41467-019-13751-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13751-9</ArticleId><ArticleId IdType="pmc">PMC6911092</ArticleId><ArticleId IdType="pubmed">31836714</ArticleId></ArticleIdList></Reference><Reference><Citation>Faizo A.A., Qashqari F.S., El-Kafrawy S.A., Barasheed O., Almashjary M.N., Alfelali M., et al. A potential association between obesity and reduced effectiveness of COVID-19 vaccine-induced neutralizing humoral immunity. J Med Virol. 2022 doi: 10.1002/jmv.28130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28130</ArticleId><ArticleId IdType="pmc">PMC9539352</ArticleId><ArticleId IdType="pubmed">36068377</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto S., Saito M., Tamura A., Prawisuda D., Mizutani T., Yotsuyanagi H. The human microbiome and COVID-19: a systematic review. PLoS One. 2021;16(6) doi: 10.1371/journal.pone.0253293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253293</ArticleId><ArticleId IdType="pmc">PMC8221462</ArticleId><ArticleId IdType="pubmed">34161373</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijay S., Bansal N., Rao B.K., Veeraraghavan B., Rodrigues C., Wattal C., et al. Secondary infections in hospitalized COVID-19 patients: Indian experience. Infect Drug Resist. 2021;14:1893–1903. doi: 10.2147/IDR.S299774.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S299774</ArticleId><ArticleId IdType="pmc">PMC8164345</ArticleId><ArticleId IdType="pubmed">34079300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginsburg A.S., Klugman K.P. COVID-19 pneumonia and the appropriate use of antibiotics. Lancet Glob Health. 2020;8(12):e1453–e1454. doi: 10.1016/S2214-109X(20)30444-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(20)30444-7</ArticleId><ArticleId IdType="pmc">PMC7833845</ArticleId><ArticleId IdType="pubmed">33188730</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao Q., Ma Y., Ling Y., Jin W., Su Y., Wang Q., et al. Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: a cohort study in Shanghai. J Microbiol Immunol Infect. 2021;54(5):808–815. doi: 10.1016/j.jmii.2021.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2021.03.015</ArticleId><ArticleId IdType="pmc">PMC8021444</ArticleId><ArticleId IdType="pubmed">34103263</ArticleId></ArticleIdList></Reference><Reference><Citation>Koehler P., Cornely O.A., Bottiger B.W., Dusse F., Eichenauer D.A., Fuchs F., et al. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020;63(6):528–534. doi: 10.1111/myc.13096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/myc.13096</ArticleId><ArticleId IdType="pmc">PMC7267243</ArticleId><ArticleId IdType="pubmed">32339350</ArticleId></ArticleIdList></Reference><Reference><Citation>Musuuza J.S., Watson L., Parmasad V., Putman-Buehler N., Christensen L., Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS One. 2021;16(5) doi: 10.1371/journal.pone.0251170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251170</ArticleId><ArticleId IdType="pmc">PMC8101968</ArticleId><ArticleId IdType="pubmed">33956882</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Ai J.W., Yang W., Zhou X., He F., Xie S., et al. Metatranscriptomic characterization of coronavirus disease 2019 identified a host transcriptional classifier associated with immune signaling. Clin Infect Dis. 2021;73(3):376–385. doi: 10.1093/cid/ciaa663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa663</ArticleId><ArticleId IdType="pmc">PMC7314197</ArticleId><ArticleId IdType="pubmed">32463434</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>